Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Oxedrine
2. Sympaethamin
3. Synephrin
1. Oxedrine
2. 94-07-5
3. P-synephrine
4. Parasympatol
5. Sympaethamine
6. Sympatol
7. Analeptin
8. Sympaethamin
9. Synephrin
10. Synthenate
11. Simpalon
12. (+/-)-synephrine
13. Simpatol
14. Ethaphene
15. Sympathol
16. Dl-synephrine
17. P-oxedrine
18. 4-(1-hydroxy-2-(methylamino)ethyl)phenol
19. 4-[1-hydroxy-2-(methylamino)ethyl]phenol
20. Synefrin
21. Advantra Z
22. 1-(4-hydroxyphenyl)-n-methylethanolamine
23. (rs)-1-(4-hydroxyphenyl)-2-(methylamino)ethanol
24. 1-(4-hydroxyphenyl)-2-methylaminoethanol
25. Nsc 166285
26. Chebi:29081
27. S 38537-9
28. Nsc-166285
29. Nsc-170956
30. Beta-methylamino-alpha-(4-hydroxyphenyl)ethyl Alcohol
31. Peg5dp7434
32. P-hydroxy-alpha-((methylamino)methyl)benzyl Alcohol
33. 4-hydroxy-alpha-((methylamino)methyl)benzenemethanol
34. Mfcd00002370
35. Nsc166285
36. Benzenemethanol, 4-hydroxy-.alpha.-[(methylamino)methyl]-
37. Benzenemethanol, 4-hydroxy-a-[(methylamino)methyl]-, (ar)-
38. 1-(4-hydroxyphenyl)-(2-methylamino)ethanol
39. Wln: Qr Dyq1m1
40. Dsstox_cid_10588
41. Dsstox_rid_78850
42. Synefrin [czech]
43. Dsstox_gsid_30588
44. P-hydroxy-alpha-[(methylamino)methyl]benzyl Alcohol
45. Pentedrin [german]
46. 4-hydroxy-alpha-[(methylamino)methyl]benzenemethanol
47. P-((methylamino)ethanol)phenol
48. P-[(methylamino)ethanol]phenol
49. P-hydroxy-.alpha.-[(methylamino)methyl]benzyl Alcohol
50. Parakorper [german]
51. S-38537-9
52. 1-(4-hydroxyphenyl)-2-(methylamino)ethanol
53. .beta.-methylamino-.alpha.-(4-hydroxyphenyl)ethyl Alcohol
54. Benzyl Alcohol, P-hydroxy-.alpha.-[(methylamino)methyl]-
55. Parakorper
56. P-hydroxyphenyl(methylamino)ethanol
57. P-methylaminoethanolphenol
58. Smr000059111
59. Synepherine
60. 1-(4-hydroxyphenyl)-(n-methylethanol)amine
61. P-hydroxyphenylmethylaminoethanol
62. Benzyl Alcohol, P-hydroxy-alpha-((methylamino)methyl)-, (-)-
63. Oxedrine [inn:ban]
64. ((methylamino)methyl)((4-hydroxyphenyl)carbinol)
65. [(methylamino)methyl][(4-hydroxyphenyl)carbinol]
66. Sr-01000002983
67. P-hydroxy-.alpha.-[(methylamino)methyl]benzylalcohol
68. Einecs 202-300-9
69. (+-)-n-methyloctopamine
70. Unii-peg5dp7434
71. Methylaminomethyl(4-hydroxyphenyl)carbinol
72. Benzenemethanol, 4-hydroxy-alpha-((methylamino)methyl)-
73. Rac-synephrine
74. Benzenemethanol, 4-hydroxy-.alpha.-((methylamino)methyl)-
75. (y)-synephrine
76. Synephrine,(s)
77. Cas-94-07-5
78. Ncgc00016351-01
79. Oxedrine, Sympatol
80. (?)-synephrine
81. Oxedrine (ban)
82. (+/-)synephrine
83. (+,-)-synephrine
84. Nsc 170956
85. Synephrine (oxedrine)
86. Synephrine - Oxedrine
87. Alpha-(4-oxyphenyl)alpha-oxy-beta-methylaminoaethan [german]
88. Synephrine [mi]
89. Prestwick0_001088
90. Prestwick1_001088
91. Prestwick2_001088
92. Prestwick3_001088
93. (.+/-.)-synephrine
94. Synephrine [inci]
95. Oxedrine [mart.]
96. Oxedrine [who-dd]
97. Synephrine [usp-rs]
98. 4-hydroxy-alpha-(methylaminomethyl)benzyl Alcohol
99. Lopac0_001085
100. (+/-)-oxedrine
101. Bspbio_001136
102. Alpha-(4-oxyphenyl)alpha-oxy-beta-methylaminoaethan
103. Mls000069435
104. Mls001424216
105. Chembl33720
106. Schembl146500
107. Spbio_003028
108. Synephrine, Analytical Standard
109. (.+/-.)-n-methyloctopamine
110. Bpbio1_001250
111. Oxedrine [usp Impurity]
112. Dtxsid0030588
113. (+/-)-synephrine, >=98%
114. Benzyl Alcohol, P-hydroxy-alpha-((methylamino)methyl)-
115. Hms1571i18
116. Hms2052g09
117. Hms2098i18
118. Hms2233f20
119. Hms3263i12
120. Hms3264e11
121. Hms3369c13
122. Hms3394g09
123. Hms3656o09
124. Hms3715i18
125. Hms3884d15
126. Pharmakon1600-01506085
127. Albb-025740
128. Hy-n0132
129. Tox21_110390
130. Tox21_200962
131. Tox21_501085
132. ( Inverted Question Mark)-synephrine
133. Bbl015111
134. Bdbm50102660
135. Nsc170956
136. Nsc759316
137. Pdsp1_000167
138. Pdsp2_000166
139. S2362
140. Stk803113
141. Akos004119915
142. Akos016038542
143. Tox21_110390_1
144. Ccg-101098
145. Ccg-205162
146. Db09203
147. Ks-5152
148. Lp01085
149. Nc00348
150. Nsc-759316
151. Sdccgsbi-0051055.p003
152. Ncgc00015924-03
153. Ncgc00015924-04
154. Ncgc00015924-05
155. Ncgc00015924-06
156. Ncgc00015924-08
157. Ncgc00015924-09
158. Ncgc00015924-12
159. Ncgc00015924-13
160. Ncgc00015924-25
161. Ncgc00089788-02
162. Ncgc00089788-03
163. Ncgc00089788-04
164. Ncgc00258515-01
165. Ncgc00261770-01
166. (+)-[(methylamino)methyl]-benzenemethano
167. 4-(1-hydroxy-2-methylamino-ethyl)phenol
168. Bp-12742
169. Synephrine 100 Microg/ml In Acetonitrile
170. Sbi-0051055.p002
171. Ab00514040
172. Cs-0007857
173. Eu-0101085
174. Ft-0618685
175. Ft-0653012
176. N1706
177. S0232
178. Sw197214-5
179. 4-[1-hydroxy-2-(methylamino)ethyl]phenol #
180. 4-hydroxy-a-(methylaminomethyl)benzyl Alcohol
181. 94s075
182. C04548
183. D07148
184. S 0752
185. Ab00384265_11
186. Q421351
187. Q-100668
188. Sr-01000002983-3
189. Sr-01000002983-7
190. Sr-01000002983-8
191. W-100214
192. 4-hydroxy-.alpha.-((methylamino)methyl)benzenemethanol
193. 7336264b-edc9-42c5-939b-ff800ab5bb4a
194. Benzenemethanol, 4-hydroxy-alpha-[(methylamino)methyl]-, 2,3-dihydroxybutanedioate (1:1) (salt)
Molecular Weight | 167.20 g/mol |
---|---|
Molecular Formula | C9H13NO2 |
XLogP3 | -0.6 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 3 |
Exact Mass | 167.094628657 g/mol |
Monoisotopic Mass | 167.094628657 g/mol |
Topological Polar Surface Area | 52.5 Ų |
Heavy Atom Count | 12 |
Formal Charge | 0 |
Complexity | 122 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Adrenergic alpha-Agonists
Drugs that selectively bind to and activate alpha adrenergic receptors. (See all compounds classified as Adrenergic alpha-Agonists.)
Sympathomimetics
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
Vasoconstrictor Agents
Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)
Nasal Decongestants
Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993) (See all compounds classified as Nasal Decongestants.)
C - Cardiovascular system
C01 - Cardiac therapy
C01C - Cardiac stimulants excl. cardiac glycosides
C01CA - Adrenergic and dopaminergic agents
C01CA08 - Oxedrine
S - Sensory organs
S01 - Ophthalmologicals
S01G - Decongestants and antiallergics
S01GA - Sympathomimetics used as decongestants
S01GA06 - Oxedrine
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?